Hepatitis A vaccine versus immune globulin for postexposure prophylaxis [2]

PING-ING LEE2021-01-072021-01-0720080028-4793https://www.scopus.com/inward/record.uri?eid=2-s2.0-38749100171&doi=10.1056%2fNEJMc073258&partnerID=40&md5=dbf21fd45ae97768b7eb210b8f1af7a2https://scholars.lib.ntu.edu.tw/handle/123456789/539586[SDGs]SDG2[SDGs]SDG3hepatitis A vaccine; immunoglobulin; alanine aminotransferase blood level; disease severity; hepatitis A; human; letter; priority journal; prophylaxis; risk factor; seroprevalence; vaccinationHepatitis A vaccine versus immune globulin for postexposure prophylaxis [2]letter10.1056/NEJMc0732582-s2.0-38749100171